在治疗抑郁症-一个覆盖性审查中预测幻觉药物的有效性
James Chmiel1, Filip Rybakowski2
1Faculty of Physical Culture and Health, Institute of Physical Culture Sciences, University of Szczecin, Al. Piastów 40B blok 6, 71-065 Szczecin, Poland.
International journal of molecular sciences
|March 14, 2026
概括
迷幻药辅助疗法显示出可变的抗抑郁药反应. 在会话中的经历,如情绪突破和积极的设置/设置因素,而不是基线特征,最强烈地预测了症状的减少.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
背景情况:
- 迷幻辅助疗法 (PAT) 提供快速的抗抑郁作用,但具有显著的响应变异性.
- 识别预测因子和调节因子对于优化PAT对于治疗耐药性抑郁症等疾病至关重要.
研究的目的:
- 综合地绘制和综合有关抗抑郁药对经典/血清激素精神药物的抗抑郁反应预测因子的证据.
- 了解患者特征,设置/设置,会话体验和生物标记在PAT结果中的作用.
主要方法:
- 根据PRISMA-ScR指南进行范围审查,搜索主要数据库和试验注册表.
- 包括随机试验,开放标签研究和自然主义队列报告预测因素-结果关联.
- 绘制研究特征,分析方法和稳定性指标.
主要成果:
- 会议中的因素,特别是情绪突破和神秘体验,是抗抑郁药物改善的最强有力的预测因素.
- 积极的治疗联盟和共振音乐增强了急性经历和临床收益.
- 基线调节剂具有混合效应;生物标志物表明神经灵活性和可塑性增加.
结论:
- 在PAT中,抗抑郁药的反应主要是由会话体验和情境因素驱动的,而不是静态的患者特征.
- 优化准备,治疗联盟,音乐,情绪处理和焦虑管理是关键的可行的策略.
- 未来的研究应该标准化措施,验证主持人/调解人,并全面评估会议中的现象和生理学.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Depressive Disorders: Etiology
827
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
827
Antidepressant Drugs: Overview
1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Elements Crucial for Effective Psychotherapy
412
Research has highlighted several critical factors that influence the effectiveness of psychotherapy, such as the therapeutic alliance, the therapist, and the client.
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
412
Electroconvulsive Therapy
1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K


